Pancreatic islets of obese hyperglycemic mice (ob/ob)
- PMID: 1594559
- DOI: 10.1097/00006676-199205000-00015
Pancreatic islets of obese hyperglycemic mice (ob/ob)
Abstract
The development of the obesity-associated hyperglycemic syndrome in ob/ob mice, genetically determined, was observed over time by a combined functional and structural study of pancreatic islets. Islet areas increased with advancing age in ob/ob mice from 2 times at 1 month to 30 times at 6 months of age the size of lean mouse islets. Islet areas apparently increased more than pancreatic insulin content in ob/ob mice. Glucose and insulin tolerance tests were performed to study in vivo responses to glucose and insulin, respectively, in 1-, 3-, and 6-month-old mice. With ob/ob mice, glucose tolerance tests revealed more elevation of plasma glucose than in lean mice, the lean mice revealing more elevated plasma insulin than the obese mice. In insulin tolerance tests, lean mice presented marked hypoglycemia, whereas ob/ob mice revealed slightly higher plasma glucose at 1 month of age but three to four times higher amounts than that of lean mice at 6 months of age. Thus, increasing insulin resistance in ob/ob mice older than 3 months is associated with progressively increasing islet area, which contains proportionally less insulin than that of lean mouse pancreas. The data suggest that insulin resistance in ob/ob mice progressively develops up to 6 months of age and that marked islet hyperplasia is likely in response to sustained hyperglycemia, leading to hyperinsulinemia and eventual marked obesity.
Similar articles
-
Vagotomy in young obese hyperglycemic mice: effects on syndrome development and islet proliferation.Am J Physiol. 1998 Jun;274(6):E1034-9. doi: 10.1152/ajpendo.1998.274.6.E1034. Am J Physiol. 1998. PMID: 9611153
-
Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.Gastroenterology. 2010 Sep;139(3):857-68. doi: 10.1053/j.gastro.2010.05.006. Epub 2010 Jun 11. Gastroenterology. 2010. PMID: 20546737
-
Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.Regul Pept. 2011 Oct 10;170(1-3):43-51. doi: 10.1016/j.regpep.2011.04.011. Epub 2011 May 26. Regul Pept. 2011. PMID: 21620903
-
The physiology of obese-hyperglycemic mice [ob/ob mice].ScientificWorldJournal. 2007 May 29;7:666-85. doi: 10.1100/tsw.2007.117. ScientificWorldJournal. 2007. PMID: 17619751 Free PMC article. Review.
-
beta-cell function in obese-hyperglycemic mice [ob/ob Mice].Adv Exp Med Biol. 2010;654:463-77. doi: 10.1007/978-90-481-3271-3_20. Adv Exp Med Biol. 2010. PMID: 20217510 Review.
Cited by
-
β-cell metabolic alterations under chronic nutrient overload in rat and human islets.Islets. 2012 Nov-Dec;4(6):379-92. doi: 10.4161/isl.22720. Epub 2012 Nov 1. Islets. 2012. PMID: 23247575 Free PMC article.
-
Intra-islet lesions and lobular variations in β-cell mass expansion in ob/ob mice revealed by 3D imaging of intact pancreas.Sci Rep. 2016 Oct 7;6:34885. doi: 10.1038/srep34885. Sci Rep. 2016. PMID: 27713548 Free PMC article.
-
A metabolome-wide characterization of the diabetic phenotype in ZDF rats and its reversal by pioglitazone.PLoS One. 2018 Nov 27;13(11):e0207210. doi: 10.1371/journal.pone.0207210. eCollection 2018. PLoS One. 2018. PMID: 30481177 Free PMC article.
-
ΔFosB Requires Galanin, but not Leptin, to Increase Bone Mass via the Hypothalamus, but both are needed to increase Energy expenditure.J Bone Miner Res. 2019 Sep;34(9):1707-1720. doi: 10.1002/jbmr.3741. Epub 2019 Jul 30. J Bone Miner Res. 2019. PMID: 30998833 Free PMC article.
-
Animal models for type 1 and type 2 diabetes: advantages and limitations.Front Endocrinol (Lausanne). 2024 Feb 20;15:1359685. doi: 10.3389/fendo.2024.1359685. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38444587 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous